Early Engagement with HTA Bodies
In-depth guide to successful early HTA engagement.
Certara2021年5月10日
Evidence generation in Europe- How valuable is the French National administrative health data (SNDS)
Evidence generation in Europe- How valuable is the French National administrative health data (SNDS)
Watch this presentation to learn • Overview of the SNDS and the key working practices…
Certara2021年5月7日
Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States
Authors: Joseph McGuirk, Clint Divine, Seung Hyun Moon, Aastha Chandak, Zhiji Zhang, Genovefa A. Papanicolaou…
Certara2021年4月8日
Legislators: Bring all stakeholders to the table to lower drug costs
BY ROMAN CASCIANO, OPINION CONTRIBUTOR — 03/29/21 05:30 PM EDT No one is happy with the…
Certara2021年3月30日
Strategic Evidence & Value Communication Symposium
Join us on 2021年4月21日 (水曜日), from12:00 PM – 2:00 PM EDT for Certara’s…
Certara2021年3月26日
Getting Gene Therapies to Patients
This blog discusses the challenges that drug developers face in getting patients access to cell…
Certara2021年2月16日
Early Value Assessment in Gene Therapy Clinical Trial Design
A global biotechnology company engineering precision genetic medicine for rare diseases was in need of…
Certara2021年2月12日
Getting Real with RWE
By Taren Grom Real-world evidence, important for regulatory decision-making, is beginning to touch all areas…
Certara2020年11月20日
SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU
In this webinar, our experts provided an overview of the SNDS and the key working…
Certara2020年10月20日
